Optivite P.M.T.
by Optimox

I. GENERAL INFORMATION

FORMULATION

Per 6 Tablets: Vitamin A 12,500 IU; Retinyl Palmitate 5,000 IU; B-Carotene 7,500 IU; Vitamin E 100 IU; Folic Acid 200 mcg; Vitamin B1 (Thiamine Mono) 25 mg; Vitamin B2 (Riboflavin) 25 mg; Niacinamide 25 mg; Vitamin B6 (Pyridoxine HCL) 300 mg; Vitamin B12a 62.5 mcg; Pantothenic Acid (D-Cal. Pan.) 25 mg; Choline Bitartrate 312.5 mg; Vitamin C (Ascorbic Acid) 1,500 mg; Magnesium (Amino Acid Chelate) 250 mg; Iodine (Hydrolyzed Protein Complex) 75 mcg; Iron (Amino Acid Chelate) 15 mg; Zinc (Amino Acid Chelate) 25 mg; Manganese (Amino Acid Chelate) 10 mg; Potassium (Hydrolyzed Protein Complex) 47.5 mg; Selenium (Hydrolyzed Protein Complex) 100 mcg; Chromium (Hydrolyzed Protein Complex) 100 mcg

Inactive Ingredients
Calcium (Amino Acid Chelate); Citrus Bioflavonoids; Betaine Acid HCL; Pancreatin (Fungal Analog); Inositol; Para Amino Benzoic Acid; Rutin; Copper (Amino Acid Chelate); Biotin; Vitamin D3

SUGGESTED USE

2-6 Tablets/day as part of the dietary program described in the brochure inside bottle, or as directed by a physician.

REFERENCES

1. Abraham, G.E., Rumley, R.E., The Role of Nutrition in Managing the Premenstrual Tension Syndromes, J. Rep. Med., 32:405, 1987.
2. Goei, G.S., Abraham, G.E., Effect of a Nutritional Supplement, Optivite®, on Symptoms of Premenstrual Tension, J. Rep. Med., 28:527, 1983.
3. Fuchs, N., Hakim, M., Abraham, G.E., The Effect of a Nutritional Supplement, Optivite® for Women, on Premenstrual Tension Syndromes: Effect on blood chemistry and serum steroid levels during the medluteal phase, J. Appl. Nut., 37:1, 1985.
4. Chakmakjian, Z.H., Higgins, C.E., Abraham, G.E., The Effect of a Nutritional Supplement, Optivite® for Women, on Premenstrual Tension Syndromes: Effect of symptomatology, using a double blind crossover design, J. Appl. Nut., 37:12, 1985.
5. London, R.S., Bradley, L., Chiamori, N.Y., Effect of a Nutritional Supplement on Premenstrual Symptomatology in Women with Premenstrual Syndrome: A Double-Blind Longitudinal Study, J. Am. Coll. Nut., 10:494-499, 1991.
6. Abraham, G.E., Nutrition and the Premenstrual Tension Syndromes, J. Appl. Nut., 36:103, 1984.
7. Abraham, G.E., Nutritional Factors in the Etiology of the Premenstrual Tension Syndromes, J. Rep. Med., 28:446, 1983.

WARNING

1. Do not use if outer seal is broken.
2. if pregnant or lactating, consult physician before use.
3. Do not exceed 6 tablets a day.
4. If taking any prescription drug, consult physician before use.
5. Do not use for pernicious anemia, or if you have hemochromatosis or hemosiderosis.
6. Read brochure inside bottle before use.
7. Accidental over dose of iron-containing products is a leading causes of fatal poisoning in children under the age of 6 years. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.